Law
Offices of Howard G. Smith announces that it is investigating
potential claims on behalf of investors of Sanofi (the “Company”)
(NYSE:SNY) concerning possible violations of federal securities laws.
The investigation is focused on the Company’s operations and financial
performance.
Sanofi discovers, develops and distributes therapeutic solutions,
including pharmaceuticals and vaccines used by veterinarians, consumer
health care products, and generic medicines. The investigation is
related to allegations that Sanofi misrepresented or failed to disclose
that the Company was making improper payments to healthcare
professionals in connection with the sale of pharmaceutical products, in
violation of federal law, and that Sanofi’s internal controls over
financial reporting were inadequate.
If you purchased Sanofi shares between February 7, 2013 and December 3,
2014, if you have information or would like to learn more about these
claims, or if you have any questions concerning this announcement or
your rights or interests with respect to these matters, please contact
Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070
Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at
(215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at www.howardsmithlaw.com.
Copyright Business Wire 2015